Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Leases: 2020-2025

Historic Leases for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $2.3 million.

  • Insight Molecular Diagnostics' Leases fell 22.03% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 22.03%. This contributed to the annual value of $2.8 million for FY2024, which is 68.42% up from last year.
  • As of Q3 2025, Insight Molecular Diagnostics' Leases stood at $2.3 million, which was down 7.29% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Leases peaked at $4.0 million during Q2 2023, and registered a low of $537,000 during Q2 2021.
  • Moreover, its 3-year median value for Leases was $2.6 million (2024), whereas its average is $2.8 million.
  • In the last 5 years, Insight Molecular Diagnostics' Leases plummeted by 84.19% in 2021 and then surged by 551.58% in 2022.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Leases stood at $3.5 million in 2021, then tumbled by 37.73% to $2.2 million in 2022, then dropped by 24.87% to $1.6 million in 2023, then soared by 68.42% to $2.8 million in 2024, then dropped by 22.03% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $2.5 million for Q2 2025, and $2.6 million during Q1 2025.